Show simple item record

Lu-177-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update

dc.contributor.authorKabasakal, Levent
dc.contributor.authorDemirci, Emre
dc.contributor.authorToklu, Turkay
dc.contributor.authorAraman, Ahmet
dc.contributor.authorOcak, Meltem
dc.contributor.authorŞahin, Onural Alper
dc.contributor.authorAlan-Selcuk, Nalan
dc.date.accessioned2021-03-06T21:26:28Z
dc.date.available2021-03-06T21:26:28Z
dc.date.issued2018
dc.identifier.citationDemirci E., Kabasakal L., Toklu T., Ocak M., Şahin O. A. , Alan-Selcuk N., Araman A., "Lu-177-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update", NUCLEAR MEDICINE COMMUNICATIONS, cilt.39, ss.789-796, 2018
dc.identifier.issn0143-3636
dc.identifier.othervv_1032021
dc.identifier.otherav_feb3afb8-9b75-4ef1-8a83-c9e3029646aa
dc.identifier.urihttp://hdl.handle.net/20.500.12627/166554
dc.identifier.urihttps://doi.org/10.1097/mnm.0000000000000874
dc.description.abstractPurpose Upon diagnosis, distant metastases are encountered in 21-50% of neuroendocrine tumours (NETs). However, few systemic treatment options are available for the well-differentiated NETs in the metastatic stage. Lu-177-DOTATATE is one of the most effective treatments in this limited patient group. We retrospectively investigated its efficacy and effect on the survival in patients with both well-differentiated and grade III NETs who had high uptake in pretherapeutic Ga-68-DOTATATE PET/computed tomography scans.
dc.language.isoeng
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectNükleer Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleLu-177-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update
dc.typeMakale
dc.relation.journalNUCLEAR MEDICINE COMMUNICATIONS
dc.contributor.departmentİstanbul Teknik Üniversitesi , Denizcilik , Deniz Ulaştırma İşletme Mühendisliği
dc.identifier.volume39
dc.identifier.issue8
dc.identifier.startpage789
dc.identifier.endpage796
dc.contributor.firstauthorID82088


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record